Supramolecular Arrangement of Doxycycline with Sulfobutylether-β-Cyclodextrin: Impact on Nanostructuration with Chitosan, Drug Degradation and Antimicrobial Potency
- Autores
- Carvalho Feitosa, Renata; Souza Ribeiro Costa, Juliana; van Vliet Lima, Marcelo; Sawa Akioka Ishikawa, Elina; Cogo Müller, Karina; Bonin Okasaki, Fernando; Sabadini, Edvaldo; Garnero, Claudia; Longhi, Marcela Raquel; Lavayen, Vladimir; da Silva Júnior, Arnóbio Antônio; Oliveira Nascimento, Laura
- Año de publicación
- 2023
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Doxycycline (DX) is a well-established and broad-spectrum antimicrobial drug. However, DX has drawbacks, such as physicochemical instability in aqueous media and bacterial resistance. The inclusion of drugs in cyclodextrin complexes and their loading into nanocarriers can overcome these limitations. Thus, we studied the DX/sulfobutylether-β-CD (SBE-β-CD) inclusion complex for the first time and used it to reticulate chitosan. The resulting particles were evaluated by their physicochemical characteristics and antibacterial activity. DX/SBE-β-CD complexes were characterized by nuclear magnetic resonance, infrared spectroscopy, thermal analysis, X-ray diffraction, and scanning electron microscopy (SEM), whereas DX-loaded nanoparticles were characterized by dynamic light scattering, SEM, and drug content. The partial inclusion of the DX molecule in CD happened in a 1:1 proportion and brought increased stability to solid DX upon thermal degradation. Chitosan-complex nanoparticles measured approximately 200 nm, with a narrow polydispersity and particles with sufficient drug encapsulation for microbiological studies. Both formulations preserved the antimicrobial activity of DX against Staphylococcus aureus, whereas DX/SBE-β-CD inclusion complexes were also active against Klebsiella pneumoniae, indicating the potential use of these formulations as drug delivery systems to treat local infections.
Fil: Carvalho Feitosa, Renata. Universidade Estadual de Campinas; Brasil
Fil: Souza Ribeiro Costa, Juliana. Universidade Estadual de Campinas; Brasil
Fil: van Vliet Lima, Marcelo. Universidade Estadual de Campinas; Brasil
Fil: Sawa Akioka Ishikawa, Elina. Universidade Estadual de Campinas; Brasil
Fil: Cogo Müller, Karina. Universidade Estadual de Campinas; Brasil
Fil: Bonin Okasaki, Fernando. Universidade Estadual de Campinas; Brasil
Fil: Sabadini, Edvaldo. Universidade Estadual de Campinas; Brasil
Fil: Garnero, Claudia. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; Argentina
Fil: Longhi, Marcela Raquel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; Argentina. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacia; Argentina
Fil: Lavayen, Vladimir. Universidade Federal do Rio Grande do Sul; Brasil
Fil: da Silva Júnior, Arnóbio Antônio. Universidade Federal do Rio Grande do Norte; Brasil
Fil: Oliveira Nascimento, Laura. Universidade Estadual de Campinas; Brasil - Materia
-
cyclodextrin
chitosan
doxycycline
nanoparticle - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/231546
Ver los metadatos del registro completo
id |
CONICETDig_b7c3b1ab4cef95a5a5005bd76d710ea9 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/231546 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Supramolecular Arrangement of Doxycycline with Sulfobutylether-β-Cyclodextrin: Impact on Nanostructuration with Chitosan, Drug Degradation and Antimicrobial PotencyCarvalho Feitosa, RenataSouza Ribeiro Costa, Julianavan Vliet Lima, MarceloSawa Akioka Ishikawa, ElinaCogo Müller, KarinaBonin Okasaki, FernandoSabadini, EdvaldoGarnero, ClaudiaLonghi, Marcela RaquelLavayen, Vladimirda Silva Júnior, Arnóbio AntônioOliveira Nascimento, Lauracyclodextrinchitosandoxycyclinenanoparticlehttps://purl.org/becyt/ford/2.10https://purl.org/becyt/ford/2Doxycycline (DX) is a well-established and broad-spectrum antimicrobial drug. However, DX has drawbacks, such as physicochemical instability in aqueous media and bacterial resistance. The inclusion of drugs in cyclodextrin complexes and their loading into nanocarriers can overcome these limitations. Thus, we studied the DX/sulfobutylether-β-CD (SBE-β-CD) inclusion complex for the first time and used it to reticulate chitosan. The resulting particles were evaluated by their physicochemical characteristics and antibacterial activity. DX/SBE-β-CD complexes were characterized by nuclear magnetic resonance, infrared spectroscopy, thermal analysis, X-ray diffraction, and scanning electron microscopy (SEM), whereas DX-loaded nanoparticles were characterized by dynamic light scattering, SEM, and drug content. The partial inclusion of the DX molecule in CD happened in a 1:1 proportion and brought increased stability to solid DX upon thermal degradation. Chitosan-complex nanoparticles measured approximately 200 nm, with a narrow polydispersity and particles with sufficient drug encapsulation for microbiological studies. Both formulations preserved the antimicrobial activity of DX against Staphylococcus aureus, whereas DX/SBE-β-CD inclusion complexes were also active against Klebsiella pneumoniae, indicating the potential use of these formulations as drug delivery systems to treat local infections.Fil: Carvalho Feitosa, Renata. Universidade Estadual de Campinas; BrasilFil: Souza Ribeiro Costa, Juliana. Universidade Estadual de Campinas; BrasilFil: van Vliet Lima, Marcelo. Universidade Estadual de Campinas; BrasilFil: Sawa Akioka Ishikawa, Elina. Universidade Estadual de Campinas; BrasilFil: Cogo Müller, Karina. Universidade Estadual de Campinas; BrasilFil: Bonin Okasaki, Fernando. Universidade Estadual de Campinas; BrasilFil: Sabadini, Edvaldo. Universidade Estadual de Campinas; BrasilFil: Garnero, Claudia. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; ArgentinaFil: Longhi, Marcela Raquel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; Argentina. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacia; ArgentinaFil: Lavayen, Vladimir. Universidade Federal do Rio Grande do Sul; BrasilFil: da Silva Júnior, Arnóbio Antônio. Universidade Federal do Rio Grande do Norte; BrasilFil: Oliveira Nascimento, Laura. Universidade Estadual de Campinas; BrasilMultidisciplinary Digital Publishing Institute2023-06info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/231546Carvalho Feitosa, Renata; Souza Ribeiro Costa, Juliana; van Vliet Lima, Marcelo; Sawa Akioka Ishikawa, Elina; Cogo Müller, Karina; et al.; Supramolecular Arrangement of Doxycycline with Sulfobutylether-β-Cyclodextrin: Impact on Nanostructuration with Chitosan, Drug Degradation and Antimicrobial Potency; Multidisciplinary Digital Publishing Institute; Pharmaceutics; 15; 4; 6-2023; 1-181999-4923CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.3390/pharmaceutics15041285info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:05:20Zoai:ri.conicet.gov.ar:11336/231546instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:05:20.891CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Supramolecular Arrangement of Doxycycline with Sulfobutylether-β-Cyclodextrin: Impact on Nanostructuration with Chitosan, Drug Degradation and Antimicrobial Potency |
title |
Supramolecular Arrangement of Doxycycline with Sulfobutylether-β-Cyclodextrin: Impact on Nanostructuration with Chitosan, Drug Degradation and Antimicrobial Potency |
spellingShingle |
Supramolecular Arrangement of Doxycycline with Sulfobutylether-β-Cyclodextrin: Impact on Nanostructuration with Chitosan, Drug Degradation and Antimicrobial Potency Carvalho Feitosa, Renata cyclodextrin chitosan doxycycline nanoparticle |
title_short |
Supramolecular Arrangement of Doxycycline with Sulfobutylether-β-Cyclodextrin: Impact on Nanostructuration with Chitosan, Drug Degradation and Antimicrobial Potency |
title_full |
Supramolecular Arrangement of Doxycycline with Sulfobutylether-β-Cyclodextrin: Impact on Nanostructuration with Chitosan, Drug Degradation and Antimicrobial Potency |
title_fullStr |
Supramolecular Arrangement of Doxycycline with Sulfobutylether-β-Cyclodextrin: Impact on Nanostructuration with Chitosan, Drug Degradation and Antimicrobial Potency |
title_full_unstemmed |
Supramolecular Arrangement of Doxycycline with Sulfobutylether-β-Cyclodextrin: Impact on Nanostructuration with Chitosan, Drug Degradation and Antimicrobial Potency |
title_sort |
Supramolecular Arrangement of Doxycycline with Sulfobutylether-β-Cyclodextrin: Impact on Nanostructuration with Chitosan, Drug Degradation and Antimicrobial Potency |
dc.creator.none.fl_str_mv |
Carvalho Feitosa, Renata Souza Ribeiro Costa, Juliana van Vliet Lima, Marcelo Sawa Akioka Ishikawa, Elina Cogo Müller, Karina Bonin Okasaki, Fernando Sabadini, Edvaldo Garnero, Claudia Longhi, Marcela Raquel Lavayen, Vladimir da Silva Júnior, Arnóbio Antônio Oliveira Nascimento, Laura |
author |
Carvalho Feitosa, Renata |
author_facet |
Carvalho Feitosa, Renata Souza Ribeiro Costa, Juliana van Vliet Lima, Marcelo Sawa Akioka Ishikawa, Elina Cogo Müller, Karina Bonin Okasaki, Fernando Sabadini, Edvaldo Garnero, Claudia Longhi, Marcela Raquel Lavayen, Vladimir da Silva Júnior, Arnóbio Antônio Oliveira Nascimento, Laura |
author_role |
author |
author2 |
Souza Ribeiro Costa, Juliana van Vliet Lima, Marcelo Sawa Akioka Ishikawa, Elina Cogo Müller, Karina Bonin Okasaki, Fernando Sabadini, Edvaldo Garnero, Claudia Longhi, Marcela Raquel Lavayen, Vladimir da Silva Júnior, Arnóbio Antônio Oliveira Nascimento, Laura |
author2_role |
author author author author author author author author author author author |
dc.subject.none.fl_str_mv |
cyclodextrin chitosan doxycycline nanoparticle |
topic |
cyclodextrin chitosan doxycycline nanoparticle |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/2.10 https://purl.org/becyt/ford/2 |
dc.description.none.fl_txt_mv |
Doxycycline (DX) is a well-established and broad-spectrum antimicrobial drug. However, DX has drawbacks, such as physicochemical instability in aqueous media and bacterial resistance. The inclusion of drugs in cyclodextrin complexes and their loading into nanocarriers can overcome these limitations. Thus, we studied the DX/sulfobutylether-β-CD (SBE-β-CD) inclusion complex for the first time and used it to reticulate chitosan. The resulting particles were evaluated by their physicochemical characteristics and antibacterial activity. DX/SBE-β-CD complexes were characterized by nuclear magnetic resonance, infrared spectroscopy, thermal analysis, X-ray diffraction, and scanning electron microscopy (SEM), whereas DX-loaded nanoparticles were characterized by dynamic light scattering, SEM, and drug content. The partial inclusion of the DX molecule in CD happened in a 1:1 proportion and brought increased stability to solid DX upon thermal degradation. Chitosan-complex nanoparticles measured approximately 200 nm, with a narrow polydispersity and particles with sufficient drug encapsulation for microbiological studies. Both formulations preserved the antimicrobial activity of DX against Staphylococcus aureus, whereas DX/SBE-β-CD inclusion complexes were also active against Klebsiella pneumoniae, indicating the potential use of these formulations as drug delivery systems to treat local infections. Fil: Carvalho Feitosa, Renata. Universidade Estadual de Campinas; Brasil Fil: Souza Ribeiro Costa, Juliana. Universidade Estadual de Campinas; Brasil Fil: van Vliet Lima, Marcelo. Universidade Estadual de Campinas; Brasil Fil: Sawa Akioka Ishikawa, Elina. Universidade Estadual de Campinas; Brasil Fil: Cogo Müller, Karina. Universidade Estadual de Campinas; Brasil Fil: Bonin Okasaki, Fernando. Universidade Estadual de Campinas; Brasil Fil: Sabadini, Edvaldo. Universidade Estadual de Campinas; Brasil Fil: Garnero, Claudia. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacia; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; Argentina Fil: Longhi, Marcela Raquel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Córdoba. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Unidad de Investigación y Desarrollo en Tecnología Farmacéutica; Argentina. Universidad Nacional de Córdoba. Facultad de Ciencias Químicas. Departamento de Farmacia; Argentina Fil: Lavayen, Vladimir. Universidade Federal do Rio Grande do Sul; Brasil Fil: da Silva Júnior, Arnóbio Antônio. Universidade Federal do Rio Grande do Norte; Brasil Fil: Oliveira Nascimento, Laura. Universidade Estadual de Campinas; Brasil |
description |
Doxycycline (DX) is a well-established and broad-spectrum antimicrobial drug. However, DX has drawbacks, such as physicochemical instability in aqueous media and bacterial resistance. The inclusion of drugs in cyclodextrin complexes and their loading into nanocarriers can overcome these limitations. Thus, we studied the DX/sulfobutylether-β-CD (SBE-β-CD) inclusion complex for the first time and used it to reticulate chitosan. The resulting particles were evaluated by their physicochemical characteristics and antibacterial activity. DX/SBE-β-CD complexes were characterized by nuclear magnetic resonance, infrared spectroscopy, thermal analysis, X-ray diffraction, and scanning electron microscopy (SEM), whereas DX-loaded nanoparticles were characterized by dynamic light scattering, SEM, and drug content. The partial inclusion of the DX molecule in CD happened in a 1:1 proportion and brought increased stability to solid DX upon thermal degradation. Chitosan-complex nanoparticles measured approximately 200 nm, with a narrow polydispersity and particles with sufficient drug encapsulation for microbiological studies. Both formulations preserved the antimicrobial activity of DX against Staphylococcus aureus, whereas DX/SBE-β-CD inclusion complexes were also active against Klebsiella pneumoniae, indicating the potential use of these formulations as drug delivery systems to treat local infections. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-06 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/231546 Carvalho Feitosa, Renata; Souza Ribeiro Costa, Juliana; van Vliet Lima, Marcelo; Sawa Akioka Ishikawa, Elina; Cogo Müller, Karina; et al.; Supramolecular Arrangement of Doxycycline with Sulfobutylether-β-Cyclodextrin: Impact on Nanostructuration with Chitosan, Drug Degradation and Antimicrobial Potency; Multidisciplinary Digital Publishing Institute; Pharmaceutics; 15; 4; 6-2023; 1-18 1999-4923 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/231546 |
identifier_str_mv |
Carvalho Feitosa, Renata; Souza Ribeiro Costa, Juliana; van Vliet Lima, Marcelo; Sawa Akioka Ishikawa, Elina; Cogo Müller, Karina; et al.; Supramolecular Arrangement of Doxycycline with Sulfobutylether-β-Cyclodextrin: Impact on Nanostructuration with Chitosan, Drug Degradation and Antimicrobial Potency; Multidisciplinary Digital Publishing Institute; Pharmaceutics; 15; 4; 6-2023; 1-18 1999-4923 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.3390/pharmaceutics15041285 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute |
publisher.none.fl_str_mv |
Multidisciplinary Digital Publishing Institute |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842269906811224064 |
score |
13.13397 |